# AI applies a standard weight-based heparin nomogram without adjusting for obesity, leading to supratherapeutic aPTT and increased bleeding risk

- **ID:** `medical/incorrect-use-of-iv-heparin-nomogram-in-obese-patient`
- **Domain:** medical
- **Category:** protocol_error
- **Error Code:** `HEPARIN-OBESITY-DOSING-ERROR`
- **Verification:** ai_generated
- **Fix Rate:** 86%

## Root Cause

Standard heparin nomograms use actual body weight for dosing, but in obese patients (BMI > 30), the volume of distribution for heparin is not linearly proportional to weight, and using actual weight can lead to overdosing; many nomograms recommend using adjusted body weight or a fixed maximum dose.

## Version Compatibility

| Version | Status | Introduced | Deprecated |
|---------|--------|------------|------------|
| CHEST Guidelines for Antithrombotic Therapy 2023 | active | — | — |
| ACCP Heparin Dosing Nomograms 2022 | active | — | — |

## Workarounds

1. **Use an obesity-adjusted dosing nomogram that calculates initial bolus and infusion rate using adjusted body weight (ABW = IBW + 0.4 × (actual weight - IBW)) for patients with BMI > 30.** (90% success)
   ```
   Use an obesity-adjusted dosing nomogram that calculates initial bolus and infusion rate using adjusted body weight (ABW = IBW + 0.4 × (actual weight - IBW)) for patients with BMI > 30.
   ```
2. **Implement a maximum initial infusion rate of 18 units/kg/hour based on actual body weight, with a hard cap of 2000 units/hour for patients >110 kg, as recommended by some institutional protocols.** (85% success)
   ```
   Implement a maximum initial infusion rate of 18 units/kg/hour based on actual body weight, with a hard cap of 2000 units/hour for patients >110 kg, as recommended by some institutional protocols.
   ```
3. **Require a pharmacist review of the heparin order for any patient with BMI > 35 before administration, using a clinical decision support alert.** (88% success)
   ```
   Require a pharmacist review of the heparin order for any patient with BMI > 35 before administration, using a clinical decision support alert.
   ```

## Dead Ends

- **** — Ideal body weight can underdose heparin, leading to subtherapeutic aPTT and increased risk of thrombosis. (70% fail)
- **** — Heparin clearance is not linearly proportional to weight in obesity; doses >20,000 units/day can accumulate and cause bleeding. (80% fail)
- **** — This reactive approach delays correction and increases the risk of bleeding before the first aPTT is checked. (60% fail)